Halozyme Therapeutics Director Sells Shares
Reporter NameConnaughton BernadetteRelationshipDirector, 10% OwnerTypeSellAmount$59,356SEC FilingForm 4Bernadette Connaughton, a Director and 10% Owner at Halozyme Therapeutics, sold 829 shares of Common Stock on December 1, 2025, at a price of $71.6 per share, totaling $59,356. Following the transaction, Connaughton directly owns 42,123 shares of the company. The sale was executed under a pre-arranged trading plan adopted on May 29, 2025.SEC Filing: HALOZYME THERAPEUTICS, INC. [ HALO ] - Form 4 - Dec. 01, 2025
| Reporter Name | Connaughton Bernadette |
| Relationship | Director, 10% Owner |
| Type | Sell |
| Amount | $59,356 |
| SEC Filing | Form 4 |
Bernadette Connaughton, a Director and 10% Owner at Halozyme Therapeutics, sold 829 shares of Common Stock on December 1, 2025, at a price of $71.6 per share, totaling $59,356. Following the transaction, Connaughton directly owns 42,123 shares of the company. The sale was executed under a pre-arranged trading plan adopted on May 29, 2025.
SEC Filing: HALOZYME THERAPEUTICS, INC. [ HALO ] - Form 4 - Dec. 01, 2025
